Literature DB >> 30254038

Guideline Adoption for Community-Acquired Pneumonia in the Outpatient Setting.

Lilliam Ambroggio1,2,3, Colleen Mangeot2, Eileen Murtagh Kurowski3,4, Camille Graham3,5,6, Paul Korn7, Marcie Strasser8, Charles Cavallo9, Katherine Brady10, Suzanne Campanella11, Caitlin Clohessy11, William B Brinkman3,5, Samir S Shah11,3,12.   

Abstract

BACKGROUND: The Pediatric Infectious Diseases Society and Infectious Diseases Society of America national childhood community-acquired pneumonia (CAP) guideline encouraged the standard evaluation and treatment of children who were managed as outpatients. Our objectives were to (1) increase adherence to guideline-recommended diagnostics and antibiotic treatment of CAP at 5 pediatric primary care practices (PPCPs) by using quality-improvement methods and (2) evaluate the association between guideline adherence and unscheduled follow-up visits.
METHODS: Immunocompetent children >3 months of age with no complex chronic conditions and who were diagnosed with CAP were eligible for inclusion in this stepped-wedge study. Interventions were focused on education, knowledge of colleagues' prescribing practices, and feedback sessions. Statistical process control charts were used to assess changes in recommendations and antibiotic treatment. Unscheduled follow-up visits were compared across time by using generalized estimating equations that were clustered by PPCP.
RESULTS: CAP was diagnosed in 1906 children. Guideline recommended therapy and pulse oximetry use increased from a mean baseline of 24.9% to a mean of 68.0% and from 4.3% to 85.0%, respectively, over the study period. Among children >5 years of age, but not among those who were younger, the receipt of guideline recommended antibiotics, as compared with nonguideline therapy, was associated with the increased likelihood of unscheduled follow-up (adjusted odds ratio, 2.12; 95% confidence interval: 1.31-3.43). Chest radiographs and complete blood cell counts were rarely performed at baseline.
CONCLUSIONS: Recommendations for limited use of chest radiographs and complete blood cell counts and standardized antibiotic therapy in children is supported at PPCPs. However, the guideline may need to include macrolide monotherapy as appropriate antibiotic therapy for older children.
Copyright © 2018 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30254038     DOI: 10.1542/peds.2018-0331

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

Review 1.  Prescribing drugs to overweight and obese children: Balancing efficacy and safety.

Authors:  Helene Roy; Christel Bertoldi; Catherine Farrell; Elisabeth Rousseau
Journal:  Paediatr Child Health       Date:  2021-01-21       Impact factor: 2.253

Review 2.  Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Isabela R Marques; Izabela P Calvi; Sara A Cruz; Luana M F Sanchez; Isis F Baroni; Christi Oommen; Eduardo M H Padrao; Paula C Mari
Journal:  Eur J Pediatr       Date:  2022-09-06       Impact factor: 3.860

3.  Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia.

Authors:  Susan C Lipsett; Matthew Hall; Lilliam Ambroggio; Adam L Hersh; Samir S Shah; Thomas V Brogan; Jeffrey S Gerber; Derek J Williams; Carlos G Grijalva; Anne J Blaschke; Mark I Neuman
Journal:  J Pediatr       Date:  2020-10-10       Impact factor: 4.406

4.  Radiologic Diagnosis and Hospitalization among Children with Severe Community Acquired Pneumonia: A Prospective Cohort Study.

Authors:  Meiron Hassen; Alemayehu Toma; Mulugeta Tesfay; Eyoel Degafu; Solomon Bekele; Freshwork Ayalew; Abel Gedefaw; Birkneh Tilahun Tadesse
Journal:  Biomed Res Int       Date:  2019-01-09       Impact factor: 3.411

5.  Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Yujiao Zheng; Changren Shi; Yaowei Han; Xinmin Li; Lijing Dong; Yan Li; Hui Chen; Yushui Wang; Jinsong Li; Geli Liu; Rong Ma; Fengmei Lian; Xiaolin Tong
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

6.  The influence of chest X-ray results on antibiotic prescription for childhood pneumonia in the emergency department.

Authors:  Josephine S van de Maat; Daniella Garcia Perez; Gertjan J A Driessen; Anne-Marie van Wermeskerken; Frank J Smit; Jeroen G Noordzij; Gerdien Tramper-Stranders; Charlie C Obihara; Jeanine Punt; Henriette A Moll; Rianne Oostenbrink
Journal:  Eur J Pediatr       Date:  2021-03-22       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.